The first stop for professional medicines advice

Summary of NICE guidance for Golimumab / Romiplostim / Psychosis with substance misuse / Opioid detoxification

Karoline Brennan, Senior Medicines Information Pharmacist, North West Medicines Information CentreSource North West Medicines Information CentrePublished
Topics: Bulletins and summariesHaematological disordersMental Health · Mental health and illnessMusculo-skeletal disorders ·

This edition of NICE Bites reflects current NICE guidance (as at November 2020). Please go to NICE to check for any recent updates to this guideline.

NICE Bites is a monthly bulletin which summarises key prescribing points from NICE guidance. NICE Bites No 30, May 2011 includes the following topics:

Golimumab for the treatment of psoriatic arthritis (NICE TA220),

Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura (NICE TA221),

Psychosis with coexisting substance misuse (NICE CG120),

Drug misuse: Opioid detoxification (NICE CG52).

Attachments